Cargando…

Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014–2018

Retrospective analysis of human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) use among individuals with PrEP indications demonstrates worsening disparities in uptake between early- and late-adopting states from 2014 to 2018. To end the HIV epidemic, federal and state governments must...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powers, Samuel D, Rogawski McQuade, Elizabeth T, Killelea, Amy, Horn, Tim, McManus, Kathleen A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266566/ https://www.ncbi.nlm.nih.gov/pubmed/34250195 http://dx.doi.org/10.1093/ofid/ofab293

Ejemplares similares

Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis
por: McManus, Kathleen A., et al.
Publicado: (2023)

Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States
por: McManus, Kathleen A., et al.
Publicado: (2020)

Medicaid Expansion’s Impact on Human Immunodeficiency Virus Outcomes in a Nonurban Southeastern Ryan White HIV/AIDS Program Clinic
por: McManus, Kathleen A, et al.
Publicado: (2020)

Inequities in the Geographic Accessibility of COVID-19 Biomedical Therapeutic Trials in the United States
por: Khazanchi, Rohan, et al.
Publicado: (2021)

1030. Medicaid Expansion: How Does it Impact HIV Outcomes in One Non-urban Southeastern Ryan White HIV/AIDS Program Clinic?
por: McManus, Kathleen A, et al.
Publicado: (2020)

1545. Three Site Testing for Sexually Transmitted Infections for People Living with HIV in One Southeastern Ryan White HIV/AIDS Program Clinic: First Year of Experience
por: Geba, Maria, et al.
Publicado: (2020)

A Missed Opportunity: Extragenital Screening for Gonorrhea and Chlamydia Sexually Transmitted Infections in People With HIV in a Southeastern Ryan White HIV/AIDS Program Clinic Setting
por: Geba, Maria C, et al.
Publicado: (2022)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
por: Huang, Ya-lin A., et al.
Publicado: (2018)

Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020
por: Khazanchi, Rohan, et al.
Publicado: (2023)

Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services
por: Sherbuk, J E, et al.
Publicado: (2018)

870. Coverage, Cost Sharing, and Out-of-Pocket Costs for Single-Tablet HIV Antiretroviral Regimens in Qualified Health Plans in the United States, 2018-2020
por: Khazanchi, Rohan, et al.
Publicado: (2021)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018
por: Harris, Norma S., et al.
Publicado: (2019)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
por: Haire, Bridget G
Publicado: (2015)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

Introducing riskCommunicator: An R package to obtain interpretable effect estimates for public health
por: Grembi, Jessica A., et al.
Publicado: (2022)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

Preexposure prophylaxis strategies for African–American women affected by mass incarceration
por: Adams, Joëlla W., et al.
Publicado: (2021)

Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance Programs
por: McManus, Kathleen A, et al.
Publicado: (2022)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis
por: Fuchs, Jonathan D., et al.
Publicado: (2018)

Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016–September 2018
por: Djomand, Gaston, et al.
Publicado: (2020)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
por: Fonner, Virginia A., et al.
Publicado: (2016)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

Minimizing error in estimates of the effect of interventions by accounting for baseline measurements: A simulation study analyzing effects on child growth
por: Deichsel, Emily L., et al.
Publicado: (2023)

Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men — 23 Urban Areas, 2017
por: Kanny, Dafna, et al.
Publicado: (2019)

Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men
por: McManus, Hamish, et al.
Publicado: (2020)

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vfcr60224kqs3a4k5li650c9es